Advanced glycation end-products: a review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occurring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 20 various AGEs have been detected in blood and tissues, as well as in foods.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The most abundant non-fluorescence AGEs involve carboxymethyl-lysine (CML), and carboxyethyl-lysine (CEL). Fluorescence AGEs involve methylglyoxal-lysine and pentosidine (Singh et al. 2001).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The Maillard reaction generates these highly reactive dicarbonyls, also referred to as 𝛼-oxoaldehydes, which in addition to methylglyoxal include glyoxal and 3deoxyglucosone. [17]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Research works printed but not linked: 2
- Kennedy L (1992) Glycation of immunoglobulins and serum proteins. In: Alberti KGMM, de Fronzo RA, Keen H, Zimmet P (eds) International Textbook of Dia- betes Mellitus, 2nd edn. John Wiley, Chichester pp 985±1007
- Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation end-product induced NF-kappaB acti- vation and cytokine expression. FEBS Letters 453: 283±287
Cited by
Items 401–500 of 1,005
Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine
Muthenna, P., Akileshwari, C., & Reddy, G. B. (2011) · Biochemical Journal · doi:10.1042/bj20110846 · Cited by 86
Franke, S., Sommer, M., Rüster, C., Bondeva, T., Marticke, J. K., Hofmann, G. O., Hein, G. E., & Wolf, G. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2807 · Cited by 85
Morgenstern, J., Fleming, T. H., Schumacher, D., Eckstein, V., Freichel, M., Herzig, S., & Nawroth, P. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760132 · Cited by 91
“AGEs are most likely a risk factor for the progression of late diabetic complications such as diabetic neuropathy (1, 2).”
BackgroundEvolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease
Jerums, G., Panagiotopoulos, S., Forbes, J. M., Osicka, T. M., & Cooper, M. E. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.017 · Cited by 92
Insulin Resistance Causes Human Gallbladder Dysmotility
Nakeeb, A., Comuzzie, A. G., Al-Azzawi, H., Sonnenberg, G. E., Kissebah, A. H., & Pitt, H. A. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.04.005 · Cited by 84
“These products are thought to have many effects, including covalent cross-linking of collagen and protein matrix.(34) The cross-linking of the matrix may lead to stiffening of the gallbladder wall itself, limiting its contraction, or may impair CCK egress through blood vessel basement membranes, preventing CCK interac…”
BackgroundAccumulation of modified proteins and aggregate formation in aging
Nowotny, K., Jung, T., Grune, T., & Höhn, A. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.05.016 · Cited by 89
“To gain a deeper insight into the role of AGEs in theses complications see reviews (Forbes et al., 2003; Singh et al., 2001; Wada and Yagihashi, 2005).”
BackgroundNewkirk, M. M., Goldbach‐Mansky, R. T., Lee, J., Hoxworth, J. M., McCoy, A., Yarboro, C. H., Klippel, J. H., & El-Gabalawy, H. S. (2003) · Arthritis Research & Therapy · doi:10.1186/ar622 · Cited by 89
“During inflammation proteins can be damaged by nonenzymatic glyoxidation [ 2 ,3].”
BackgroundEl‐Remessy, A. B., Rajesh, M., Mukhopadhyay, P., Horváth, B., Patel, V., Al-Gayyar, M. M. H., Pillai, B. A., & Pacher, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2061-4 · Cited by 88
“Treatment of diabetic mice or HREC cells exposed to high glucose with SR141716 attenuated the oxidative and nitrative stress, and reduced levels of nuclear factor κB, ICAM-1 and VCAM-1.”
InfluentialBraga, D. P. A. F., Halpern, G., Setti, A. S., Figueira, R. C. S., Iaconelli, A., & Borges, E. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.03.007 · Cited by 99
“These are compounds created through the non-enzymatic reaction between reducing sugars and free amino groups in proteins, lipids or nucleic acids (Singh et al., 2001).”
BackgroundMethylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
Wetzels, S., Wouters, K., Schalkwijk, C. G., Vanmierlo, T., & Hendriks, J. J. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020421 · Cited by 89
“AGER1 is a type I transmembrane protein that is supposed to facilitate AGE turnover by mediating the uptake, degradation, and removal of AGEs [40].”
BackgroundInfluentialMildner–Szkudlarz, S., Siger, A., Szwengiel, A., Przygoński, K., Wójtowicz, E., & Zawirska‐Wojtasiak, R. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.03.126 · Cited by 84
Abbas, G., Al-Harrasi, A. S., Hussain, H., Hussain, J., Rashid, R., & Choudhary, M. I. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1028080 · Cited by 86
“AGEs are complex and heterogeneous group of compounds having a vital role in diabetes-related complications (Singh et al., 2001).”
BackgroundObstructive sleep apnoea is associated with decreased insulin sensitivity in females
Theorell-Haglöw, J., Berne, C., Janson, C., & Lindberg, E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00074907 · Cited by 83
“In addition, the deoxygenation and reoxygenation cycles in OSA provide an environment with increased oxidative stress [26, 29], which, in combination with hyperglycaemia, may promote the formation of advanced glycation end-products [ 30 ].”
BackgroundGlyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update
Piarulli, F., Sartore, G., & Lapolla, A. (2013) · Acta Diabetologica · doi:10.1007/s00592-012-0412-3 · Cited by 80
“There are essentially three main mechanisms behind the tissue damage caused by AGEs, that is, intracellular glycation, cross-link formation, and interaction with specific cellular receptors [28].”
BackgroundShen, C., Ma, Y., Zeng, Z., Yin, Q., Yan, H., Hou, X., & Liu, X. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2321-x · Cited by 85
“Advanced glycation end products (AGEs) are formed via non-enzymatic reactions between glucose or other carbohydrates and stable protein deposits [10].”
Yu, L., Chai, M., Zeng, M., He, Z., & Chen, J. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.07.051 · Cited by 84
Chromatin as a key consumer in the metabolite economy
Diehl, K. L., & Muir, T. W. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0517-x · Cited by 77
Quan, W., Li, Y., Ye, J., Xue, C., Liu, G., Wang, Z., He, Z., Qin, F., Zeng, M., & Chen, J. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127387 · Cited by 82
Subramanian, U., Gopi, V., & Vellaichamy, E. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.11.013 · Cited by 83
AGEs mediated expression and secretion of TNF alpha in rat retinal microglia
Wang, A. L., Yu, A. C., He, Q. H., Zhu, X., & Tso, M. O. M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.01.011 · Cited by 82
“All rights reserved. doi:10.1016/j.exer.2007.01.011 of proteins, lipids, and DNA though a number of complex pathways, including nonenzymatic glycation by glucose and reaction with metabolic intermediates and reactive dicarbonyl intermediates (Singh et al., 2001).”
InfluentialGaller, A., Müller, G., Schinzel, R., Kratzsch, J., Kiess, W., & Münch, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2609 · Cited by 80
Couture, R., & Girolami, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.045 · Cited by 93
Update on the management of diabetic polyneuropathies
Stevens, M. J., & Shakher, J. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s11324 · Cited by 103
Level of an Advanced Glycated End Product Is Genetically Determined
Leslie, R. D. G., Beyan, H., Sawtell, P., Boehm, B. O., Spector, T. D., & Snieder, H. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2441 · Cited by 82
Chen, Y., Tang, S., Chen, Y., Zhang, R., Zhou, M., Wang, C., Feng, N., & Wu, Q. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.08.090 · Cited by 81
Lu, J., Li, M., Huang, Y., Xie, J., Shen, M., & Xie, M. (2021) · Food Control · doi:10.1016/j.foodcont.2021.108449 · Cited by 84
Dietary glycation compounds – implications for human health
Hellwig, M., Diel, P. R., Eisenbrand, G., Grune, T., Guth, S., Henle, T., Humpf, H., Joost, H., Marko, D., Raupbach, J., et al. (2024) · Critical Reviews in Toxicology · doi:10.1080/10408444.2024.2362985 · Cited by 83
Comprehensive Analysis of Maillard Protein Modifications in Human Lenses: Effect of Age and Cataract
Smuda, M., Henning, C., Raghavan, C. T., Johar, K., Vasavada, A. R., Nagaraj, R. H., & Glomb, M. A. (2015) · Biochemistry · doi:10.1021/bi5013194 · Cited by 81
Bao, J., He, M., Liu, Y., Lu, Y., Hong, Y.-Q., Luo, H., Ren, Z., Zhao, S., & Jiang, Y. (2015) · Europe PMC (PubMed Central) · Cited by 85
Liu, J., Pan, S., Wang, X., Liu, Z., & Zhang, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01431-w · Cited by 88
“One of the key factors implicated in the development of diabetes-associated CVD is the accumulation of advanced glycation end products (AGEs), a heterogeneous group of molecules formed by the non-enzymatic glycation of proteins, lipids, and nucleic acids [3].”
BackgroundDu, Y., Shi, S., Jiang, Y., Xiong, H., Woo, M. W., Zhao, Q., Bai, C., Zhou, Q., & Sun, W. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.5739 · Cited by 81
Kumaramanickavel, G., Ramprasad, V. L., Sripriya, S., Upadyay, N. K., George, P. P., & Sharma, T. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00187-3 · Cited by 80
“This affects tissue remodelling by activation of smooth muscle proliferation as well as increasing vascular permeability (Singh et al., 2001).”
BackgroundInfluentialCorneal biomechanical characteristics in patients with diabetes mellitus
Kotecha, A., Oddone, F., Sinapis, C., Elsheikh, A., Sinapis, D., Sinapis, A., & Garway‐Heath, D. F. (2010) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2010.08.027 · Cited by 87
Li, W., Chen, Z., Yan, M., He, P., Chen, Z., & Dai, H. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13436 · Cited by 80
“AGEs and RAGE trigger the cell activation and inflammatory response (Singh et al. 2001; Lu et al. 2004).”
BackgroundHyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis
LaRocca, T. J., Sosunov, S. A., Shakerley, N. L., Ten, V. S., & Ratner, A. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716027 · Cited by 83
“AGEs are formed due to the synthesis of the toxic derivative, methylglyoxal, from the fragmentation of glyceraldehyde phosphate and dihydroxyacetone phosphate during glycolysis (8, 9).”
BackgroundCavero‐Redondo, I., Soriano‐Cano, A., Álvarez‐Bueno, C., Cunha, P., Martínez‐Hortelano, J. A., Garrido‐Miguel, M., Berlanga‐Macías, C., & Martínez‐Vizcaíno, V. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009833 · Cited by 86
“Several pathophysiological pathways by which AGEs contribute to these conditions have been described, including (1) adduct formations in basement membranes that permanently change the extracellular matrix proteins, such as collagen or elastin, and (2) interaction with AGE receptors, known as receptors for advanced gly…”
BackgroundAdvanced Glycation Endproducts in Nondiabetic Patients With Obstructive Sleep Apnea
Tan, K. C. B., Chow, W.-S., Lam, J. C. M., LAM, B. K., Bucala, R., Betteridge, J. D., & Ip, M. (2006) · SLEEP · doi:10.1093/sleep/29.3.329 · Cited by 79
Serum levels of low molecular weight advanced glycation end products in diabetic subjects
Sharp, P. S., Rainbow, S. J., & Mukherjee, S. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00973.x · Cited by 79
Skin advanced glycation end product accumulation and muscle strength among adult men
Momma, H., Niu, K., Kobayashi, Y., Guan, L., Sato, M., Guo, H., Chujo, M., Otomo, A., Yufei, C., Tadaura, H., et al. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1779-x · Cited by 78
“…AGE accumulation is covalent cross-linking of AGEs to proteins, which leads to increased stiffness of protein matrix, impeding function and increasing resistance to removal of cross-linked proteins by proteolysis in various tissues and organs leading to impaired organ functions (Singh et al. 2001).”
BackgroundInfluentialSelf-citationLiao, H., Zakhaleva, J., & Chen, W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.038 · Cited by 84
“The carboxymethyllysine (CML) structure is a prevalent AGE generated principally by oxidative cleavage of the Amadori intermediate [1,2].”
BackgroundWong, C. W., Lamoureux, E. L., Cheng, C., Cheung, C. M. G., Tai, E. S., Wong, T. Y., & Sabanayagam, C. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.023 · Cited by 82
Glucose-mediated cross-linking of collagen in rat tendon and skin
Mentink, C. J. A. L., Hendriks, M., Levels, A. A. G., & Wolffenbuttel, B. H. R. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00097-9 · Cited by 79
Tokalı, F. S., Demir, Y., Türkeş, C., Dinçer, B., & Beydemir, Ş. (2023) · Drug Development Research · doi:10.1002/ddr.22031 · Cited by 80
“2023;84:275–295. wileyonlinelibrary.com/journal/ddr © 2023 Wiley Periodicals LLC. | 275 activation of polyol pathway and the enhanced activity of protein kinase C, and so on (Brownlee, 2001; Huijberts et al., 2008; R. Singh et al., 2001; D. K. Singh et al., 2011; De Vriese et al., 2000).”
BackgroundShankarappa, S. A., Piedras‐Rentería, E. S., & Stubbs, E. B. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07302.x · Cited by 76
“Reducing sugars like glucose and fructose non-enzymatically react with free amino groups of lipids, proteins and nucleic acids to form Schiff bases, ketamines, and Amadori products, which undergo slow spontaneous molecular arrangement (Amadori rearrangement) forming stable advanced glycation end-products (AGE) (Singh…”
BackgroundSaini, A. K., Kumar, A. H. S., & Sharma, S. S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.016 · Cited by 80
Wang, W., Liu, H., Wang, Z., Qi, J. R., Yuan, S., Zhang, W., Chen, H., Finley, J. W., Gu, L., & Jia, A. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2016.03.019 · Cited by 78
Sezer, A. D. (2016) · InTech eBooks · doi:10.5772/60475 · Cited by 81
Pentosidine and Nε-(carboxymethyl)-lysine in Alzheimer’s disease and vascular dementia
Bär, K., Franke, S., Wenda, B., Müller, S., Kientsch-Engel, R., Stein, G., & Sauer, H. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00086-6 · Cited by 79
“[35] Singh R, Barden A, Mori T, Beilin L.”
BackgroundRAGE: A Novel Target for Drug Intervention in Diabetic Vascular Disease
Hudson, B. I., & Schmidt, A. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032992.75423.9b · Cited by 85
“At the molecular level, the nonenzymatic glycation process occurs due to the reactive nature of aldose sugars with amino groups of proteins to form a Schiff base ( 5 ).”
BackgroundDeluyker, D., Evens, L., & Bito, V. (2017) · Amino Acids · doi:10.1007/s00726-017-2464-8 · Cited by 82
Microbial Metabolites of Flavan-3-Ols and Their Biological Activity
Campos, E. M., Stehle, P., & Simon, M. (2019) · Nutrients · doi:10.3390/nu11102260 · Cited by 80
“Advanced glycation end-products (AGEs) contribute to the occurrence of several pathologies, such as diabetes and rheumatoid arthritis [83].”
BackgroundMastrocola, R., Collotta, D., Gaudioso, G., Berre, M. L., Cento, A. S., Alves, G. F., Chiazza, F., Verta, R., Bertocchi, I., Manig, F., et al. (2020) · Nutrients · doi:10.3390/nu12092497 · Cited by 79
“The progressive ageing of world population and the rapid changes in the lifestyle occurred in recent decades have contributed to the rising of chronic metabolic and inflammatory diseases [1].”
BackgroundMoridi, H., Karimi, J., Sheikh, N., Goodarzi, M. T., Saidijam, M., Yadegarazari, R., Khazaei, M., Khodadadi, I., Tavilani, H., Piri, H., et al. (2015) · Intern J Endocrinol Metab · doi:10.5812/ijem.23542 · Cited by 77
“Advanced glycation end-products (AGEs), resulting from binding of sugars to proteins, lipids and nucleic acids by nonenzymatic reactions have been implicated as key pathogenic factors in initiation and progression of diabetic complications (4).”
BackgroundAdvanced glycation end products are associated with arterial stiffness in type 1 diabetes
Llauradó, G., Ceperuelo‐Mallafré, V., Vilardell, C., Simó, R., Gil, P., Cano, A., Vendrell, J. J., & González-Clemente, J. M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0407 · Cited by 83
“Hyperglycaemia and oxidative stress accelerate the accumulation of AGEs (Singh et al. 2001), which are involved in the development of micro- and macrovascular complications in type 1 diabetes (Genuth et al. 2005, Nin et al. 2011).”
Kaji, Y., Amano, S., Usui, T., Oshika, T., Yamashiro, K., Ishida, S., Suzuki, K., Tanaka, S., Adamis, A. P., Nagai, R., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0268 · Cited by 77
Diabetes-induced mechanophysiological changes in the small intestine and colon
Zhao, M., Liao, D., & Zhao, J. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.249 · Cited by 74
Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links
Foiles, P. G., Founds, H. W., & Vasan, S. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.11.1977 · Cited by 77
“Non-enzymatic glycosylation of proteins resulting in the accumulation of AGEs has been recognised as a causative factor in the development of diabetic complications and diseases of ageing [1-5].”
BackgroundNoncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration
Marro, M., Kossar, A. P., Xue, Y., Frasca, A., Levy, R. J., & Ferrari, G. M. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018921 · Cited by 77
Xiong, K., Li, M., Chen, Y., Hu, Y., & Wen, J. (2024) · Journal of Food Protection · doi:10.1016/j.jfp.2024.100338 · Cited by 81
Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes
Chompoo, J., Upadhyay, A., Kishimoto, W., Makise, T., & Tawata, S. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.04.034 · Cited by 76
“Glycation (non-enzymatic glycosylation) processes, also known as Maillard reaction, are a series of reactions between reducing sugars and N-terminal group of proteins in the early stages of AGEs formation (Singh et al., 2001).”
BackgroundInfluentialWeihrauch, D., Lohr, N. L., Mraović, B., Ludwig, L. M., Chilian, W. M., Pagel, P. S., Warltier, D. C., & Kersten, J. R. (2004) · Circulation · doi:10.1161/01.cir.0000129225.67353.1f · Cited by 81
Khazaei, M., Karimi, J., Sheikh, N., Goodarzi, M. T., Saidijam, M., Khodadadi, I., & Moridi, H. (2015) · Phytotherapy Research · doi:10.1002/ptr.5501 · Cited by 78
“…in the diabetic group of this study could be speculated because of both overproduction by hyperglycemia condition and decreased excretion of AGEs by impaired function of liver and kidney of diabetic rat because elimination of AGEs is dependent to normal function of this organs (Singh et al., 2001).”
BackgroundRaghavan, C. T., Smuda, M., Smith, A. J. O., Howell, S. J., Smith, D. G., Singh, A., Gupta, P., Glomb, M. A., Wormstone, I. M., & Nagaraj, R. H. (2016) · Aging Cell · doi:10.1111/acel.12450 · Cited by 76
“Glycation is the reaction of carbonyl compounds, including glucose, ascorbate oxidation products, and methylglyoxal, that forms a variety of structurally diverse stable adducts in proteins; these adducts are collectively known as advanced glycation endproducts or AGEs (Singh et al., 2001).”
BackgroundAdvanced glycation end product accumulation: a new enemy to target in chronic kidney disease?
Mallipattu, S. K., & Uribarri, J. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000062 · Cited by 82
Kumagai, Y., Nakatani, S., Onodera, H., Nagatomo, A., Nishida, N., Matsuura, Y., Kobata, K., & Wada, M. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b02766 · Cited by 82
Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS
Liu, C., Xiao, K., & Xie, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922702 · Cited by 83
Semba, R. D., Ferrucci, L., Fink, J. C., Sun, K., Beck, J., Dalal, M., Guralnik, J. M., & Fried, L. P. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.06.018 · Cited by 76
Increased Urinary Levels of Pentosidine, Pyrraline and Acrolein Adduct in Type 2 Diabetes.
Daimon, M., Sugiyama, K., Kameda, W., SAITOH, T., Oizumi, T., Hirata, A., Yamaguchi, H., Ohnuma, H., Igarashi, M., & Kato, T. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.61 · Cited by 75
Attenuation of oxidative stress in streptozotocin-induced diabetic rats by Eucalyptus globulus
Nakhaee, A., Bokaeian, M., Saravani, M., Farhangi, A. A., & Akbarzadeh, A. (2009) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-009-0075-1 · Cited by 93
“During diabetes, advanced glycation end products form when glucose reacts with various proteins such as hemoglobin, albumin, collagen, LDL, or crystalline proteins to form labile Schiff bases, which then undergo further modification to form Amadori products (28, 29 ).”
BackgroundTargeting advanced glycation with pharmaceutical agents: where are we now?
Borg, D. J., & Forbes, J. M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9691-1 · Cited by 79
“This detoxification and process of AGE elimination can occur via scavenger receptors such as SR-A, SR-BI, and CD36, which are expressed on a number of cell types [18, 19] as well as the ubiquitously expressed advanced glycation end product receptor 1 (AGE-R1) and galectin-3 (AGE-R3) [17, 19].”
BackgroundLiu, H., Wang, C., Qi, X., Zou, J., & Sun, Z. (2018) · Journal of Food Science and Technology · doi:10.1007/s13197-018-3105-2 · Cited by 75
Studies of renal injury III: Lipid-induced nephropathy in type II diabetes
Dominguez, J. H., Tang, N., Xu, W., Evan, A. P., Siakotos, A. N., Agarwal, R., Walsh, J., Deeg, M. A., Pratt, J. H., March, K. L., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00814.x · Cited by 75
Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice
Jensen, L. J. N., Denner, L., Schrijvers, B. F., Tilton, R. G., Rasch, R., & Flyvbjerg, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06524 · Cited by 76
“Non-enzymatic glycation occurs through a series of biochemical reactions between glucose and other reactive carbonyl compounds, proteins, lipids or nucleic acids (Singh et al. 2001).”
BackgroundAdvanced Glycation End Products (AGEs) Induce Apoptosis via a Novel Pathway
Mahali, S., Raviprakash, N., Raghavendra, P. B., & Manna, S. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279190 · Cited by 70
Harsha, P. S. C. S., Gardana, C., Simonetti, P., Spigno, G., & Lavelli, V. (2013) · Bioresource Technology · doi:10.1016/j.biortech.2013.04.092 · Cited by 74
“Despite the complex patterns of protein glycation, the resulting advanced glycation endproducts (AGEs) produce the same chemical outcome, i.e., the formation of covalent cross-links between proteins, which damage their functionality (Singh et al., 2001).”
BackgroundWang, R.-T., Zhang, J.-R., Li, Y., Liu, T., & Yu, K.-J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.006 · Cited by 74
Rodríguez‐Mañas, L., Angulo, J., VALLEJO, S., Peiró, C., Sánchez‐Ferrer, A., Cercas, E., Bonnardeaux, P. L.-D., & Sánchez‐Ferrer, C. F. (2003) · Diabetologia · doi:10.1007/s00125-003-1056-1 · Cited by 80
“However, a recent review [ 63 ] states the difficulties to compare AGE determinations between laboratories, indicating that the time required for these compounds to produce pathological changes is usually of several months.”
BackgroundUchida, Y., Ohba, K.-I., Yoshioka, T., Irie, K., Muraki, T., & Maru, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304222200 · Cited by 74
Diabetes mellitus and the impairment of male reproductive function: Possible signaling pathways
Barkabi-Zanjani, S., Ghorbanzadeh, V., Aslani, M. R., Ghalibafsabbaghi, A., & Chodari, L. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.031 · Cited by 86
Bansal, S., Burman, A., & Tripathi, A. K. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i8.1146 · Cited by 81
Advanced glycation end products and diabetic retinopathy
Sharma, Y., Saxena, S., Mishra, A., Saxena, A., & Natu, S. M. (2012) · Journal of ocular biology, diseases, and informatics · doi:10.1007/s12177-013-9104-7 · Cited by 81
Kang, X., Kong, F., Wu, X., Ren, Y., Wu, S., Wu, K., Jiang, Z., & Zhang, W. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373928 · Cited by 77
Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation
Cussimanio, B. L., Booth, A. A., Todd, P., Hudson, B. G., & Khalifah, R. G. (2003) · Biophysical Chemistry · doi:10.1016/s0301-4622(03)00100-5 · Cited by 77
dos Santos, K. G., Canani, L. H. S., Gross, J. L., Tschiedel, B., Souto, K. E. P., & Roisenberg, I. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.02.010 · Cited by 73
Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes
Figarola, J. L., Shanmugam, N., Natarajan, R., & Rahbar, S. (2007) · Diabetes · doi:10.2337/db06-0936 · Cited by 73
Abdallah, H. M., El‐Bassossy, H. M., Mohamed, G. A., Halawany, A. M. E., Alshali, K. Z., & Banjar, Z. M. (2016) · Molecules · doi:10.3390/molecules21020251 · Cited by 77
“Moreover, several AGEs activate the cell surface AGE receptor (RAGE) to initiate -NF-κB and associated pro-inflammatory signaling pathways [8].”
BackgroundMori, H., Kuroda, A., Araki, M., Suzuki, R., Taniguchi, S., Tamaki, M., Akehi, Y., & Matsuhisa, M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12582 · Cited by 76
Liu, J., He, Y., Wang, S., He, Y., Wang, W., Li, Q., & Cao, X. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.06.024 · Cited by 76
Mitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome
Lee, S., Chung, D. J., Lee, H.-S., Kim, T.-J., Kim, M.-H., Jeong, H. J., Im, J., Lee, D., & Lee, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.010 · Cited by 72
Beltramo, E., Berrone, E., Buttiglieri, S., & Porta, M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.470 · Cited by 72
Gugliucci, A., & Menini, T. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02242-7 · Cited by 72
“Strong evidence from animal studies show that the glycation inhibitor aminoguanidine, attenuates the development of a range of diabetic vascular complications [4,10,11].”
BackgroundInfluentialTendon Repair Is Compromised in a High Fat Diet-Induced Mouse Model of Obesity and Type 2 Diabetes
David, M. A., Jones, K. H., Inzana, J. A., Zuscik, M. J., Awad, H. A., & Mooney, R. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091234 · Cited by 72
“The hyperglycemia of diabetes is associated with accelerated glycation of proteins and an increased accumulation of AGE crosslinking in long-lived proteins such as collagen [35,36].”
BackgroundBiochemical, biophysical, and thermodynamic analysis of in vitro glycated human serum albumin
Khan, M. W. A., Rasheed, Z., Khan, W. A., & Ali, R. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907020034 · Cited by 72
Cardiovascular Complications in Diabetes
Stirban, A. O., & Tschoepe, D. (2008) · Diabetes Care · doi:10.2337/dc08-s257 · Cited by 82
Dietary consumption of advanced glycation end products and risk of metabolic syndrome
Angoorani, P., Ejtahed, H., Mirmiran, P., Mirzaei, S., & Azizi, F. (2016) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1137889 · Cited by 73
“Studies have shown that the effect of RAGE on weight gain, abdominal obesity, adipocyte size, and development of CVD (Schmidt et al., 1994; Singh et al., 2001).”
BackgroundInfluentialDiabetes mellitus and male infertility
Omolaoye, T. S., & du Plessis, S. S. (2017) · Asian Pacific Journal of Reproduction · doi:10.4103/2305-0500.220978 · Cited by 82
“AGEs are products of non-enzymatic reaction between sugar and the amino groups of proteins, lipids and DNA under hyperglycaemic conditions[69,70].”
BackgroundPhoto-Degradation of Therapeutic Proteins: Mechanistic Aspects
Schöneich, C. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-2763-8 · Cited by 74
Diabète sucré, stress oxydant et produits de glycation avancée
Bonnefont‐Rousselot, D., Beaudeux, J., Thérond, P., Peynet, J., Legrand, A., & Delattre, J. (2004) · Annales Pharmaceutiques Françaises · doi:10.1016/s0003-4509(04)94297-6 · Cited by 93
Jing, R., CUI, M., Wang, J., & WANG, H. (2010) · Neoplasma · doi:10.4149/neo_2010_01_055 · Cited by 71
“AGEs are produced during the normal aging process and their production is accelerated in diabetes [11].”
BackgroundZhu, P., Yang, C. H., Chen, L., Ren, M., Lao, G., & Yan, L. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1102-z · Cited by 71
“Pentosidine and CML have been detected as the main AGEs in the vasculature and tissues of diabetic patients and accumulate with time in animal species tested [ 30 ].”
Background
Metadata
- Authors
- Singh, R., Barden, A., Mori, T., & Beilin, L.
- Affiliations
- The University of Western Australia (AU)
- Venue
- Diabetologia
- Published
- 2001-02-05
- Volume
- 44
- Issue
- 2
- Pages
- 129-146
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1966234811
- Cited by
- 2,597
- References
- 45
- Citations by year
- 2026: 67 · 2025: 85 · 2024: 124 · 2023: 117 · 2022: 152 · 2021: 161 · 2020: 138 · 2019: 142 · 2018: 118 · 2017: 118 · 2016: 130 · 2015: 139 · 2014: 132 · 2013: 114 · 2012: 132
- FWCI
- 36.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-30)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- advanced glycation end products, diabetes complications, diabetic microvascular complications, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic vascular disease, carbonyl stress, aminoguanidine
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Food, Humans, Plants, Toxic, Receptors, Immunologic, Nicotiana, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.